Volume 13, Issue 8 (9-2015)                   IJRM 2015, 13(8): 507-512 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Safian F, Khalili M A, Karimi-Zarchi M, Mohsenzadeh M, Ashourzadeh S, Omidi M. Developmental competence of immature oocytes aspirated from antral follicles in patients with gynecological diseases. IJRM. 2015; 13 (8) :507-512
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-673-en.html
1- Department of Biology and Anatomical Sciences, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- Department of Obstetrics and Gynecology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , drkarimi2001@yahoo.com
3- Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4- Afzalipour Clinical Center for Infertility, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran
Full-Text [PDF 213 kb]   (165 Downloads)     |   Abstract (HTML)  (1496 Views)
Full-Text:   (61 Views)
Introduction
 
Over the last decades, early detection and advances in the treatment of women diagnosed with cancer in their reproductive age have markedly increased (1). However, the effects of cancer and its treatment on fertility has emerged as a major quality of life issue for cancer survivors (2). For cancer patients, several strategies have been proposed as options for preserving fertility (3). Nowadays, in developed countries, women for financial or social reasons delay child bearing until later in life. So, the numbers of women that diagnosed with cancer in reproductive age who are interested in preserving fertility are increasing (4, 5). There are several methods for preserving the reproductive potential prior to gonadotoxic treatment, such as cryopreservation of their immature or mature oocytes, embryo and ovarian tissue (6, 7).
Recently, some studies have suggested an in vitro maturation (IVM) of immature oocytes collected from excised ovary followed by oocyte vitrification in patients undergoing ovarian cryobanking. This can be considered as good alternative methods for fertility preservation particularly for pre-pubertal girls or single women (1, 8). It provides shorter time to oocyte collection not only required hormone pre-treatment or delayed for initiation of cancer treatment (9, 10). Originally, IVM program provides a milder treatment for infertility (11). For current practice, oophorectomy can be performed for the purpose of fertility preservation prior to toxic treatment and aspirated oocytes can be cultured in vitro (12, 13).
The oocyte quality or morphology may be one of the factors determining its developmental competence and outcome of infertility treatment protocols (14). Moreover, anatomical structures of the IVM oocytes will be assessed by using the Polscope system, which does not require invasive techniques, such as fixation or staining (15). Polarized light imaging can analyze birefringent characteristics, such as the meiotic spindle (MS) and zona pellucida (ZP) in living oocytes (16). Therefore, this study aimed to evaluate the immature oocytes from ovaries removed by laparotomy or total abdominal hysterectomy (TAH) in gynecologic patients without any stimulation, then the efficiency of maturated oocytes was assessed in IVM program.
 
Materials and methods
 
Patients
In this experimental study, the excised ovarian tissues and large biopsies of the ovarian cortex from 26 patients (mean age 34.03±7.3 years) with malignant and benign gynecological diseases were removed. Out of these patients, 7 were diagnosed with squamous metaplasia, 2 cervical neoplasia, 2 papillary serous carcinoma, 7 Leiomyoma, 2 mature cystic teratoma, and 6 with other types of ovarian complications including mucinous, serous, and endometriotic cystic. The investigation took place from Dec 2013 to Dec 2014 at Yazd Institute for Reproductive Sciences, Yazd, Iran. The inclusion criteria were: age (21-45 years), partial ovarian tumor, and no prior chemotherapy. The exclusion criteria included: complete ovarian tumor or being under chemotherapy. In addition, in all recruited patients, the day of menstrual cycle and history of infertility were ignored. Ovarian samples were obtained from collaborating hospitals and transported to the research laboratory in Hams’ F10+HAS medium at 4°C within 30 min. The study was approved by Ethics Committee of Research and Clinical Center for Infertility, Yazd, Iran.
 
Oocyte retrieval
All visible antral follicles on the surface of ovaries were aspirated using scalp vein G21 gauge needles under pressure of 40-50 mm Hg. Then, using stereo microscope, the aspirated follicular fluid (FF) was examined for cumulus oocyte complexes (COCs). The immature oocytes were examined for meiotic stage and denuded oocytes were washed three times in pre-warmed IVM washing medium. Then, aspirated oocytes were placed in humidified incubator at 37°C with 5% CO2 and 95% air for 48 hr. The ovarian tissues of 9 women were lacking oocytes at any stage.
 
In vitro maturation
Immature oocytes were subsequently transferred to pre-equilibrated IVM medium consisting of: Ham’s F10 (Biochrom Co, Germany) supplemented with 0.75 IU LH, 0.75 IU FSH (Ferring Co, Germany) and 40% FF, as described previously (17). Briefly, FF was centrifuged at 3,500 rpm for 10 min to remove granulosa and blood cells, then inactivated in water bath at 56°C for 30 min. Pure HFF was filtered with a 0.22 μm filter, and aliquoted and stored at -20°C (18). Oocyte maturation was confirmed under an inverted microscope (Nikon Co, Japan) after 24 hr and 48 hr by the presence of first polar body.
 
Morphologic observations and imaging of ZP and MS
The morphology of in-vitro matured oocytes was evaluated under inverted microscope (TE300; Nikon, Japan) with a heated stage. The oocytes morphologic characteristics were determined by variables of irregular shape, presence of vacuoles, appearance of smooth endoplasmic reticulum clusters (SERc), refractile bodies (RF), wide perivitelline space (PVS), and fragmented polar body (fPB) (19-21).For polarized light microscopy, each oocyte was placed on a glass bottom dish (Wilkos, Netherlands) in a droplet of buffered medium (G-Mops-V1; Vitrolife) overlaid with mineral oil (Irvine Scientific, USA) and kept on a 37°C stage under the polarization microscope (OCTAX PolarAIDE; Octax). Immediately, the oocytes were screened for visualization of the MS and concentration and homogeny of the inner layer of ZP.
 
Statistical analysis
The data were presented as mean±SD and percentage for qualitative data. Linear correlation test was applied for analyzing data between age and number of collected oocytes (Pearson, p<0.05). Statistical evaluation was done using the SPSS software (Statistical Package for the Social Sciences version 20.0, SPSS Inc., Chicago, IL, USA).
 
Results
 
IVM outcomes of immature oocytes
In total, 61 immature oocytes from 26 patients were retrieved. Only 13 (30.2%) oocytes reached maturity and extruded first polar body. Furthermore, immature oocytes that reached the MII stage were enclosed by cumulus cells. In 9 (34.6 %) women, no oocytes were found. Also, 18 (29.5%) of the aspirated oocytes were degenerated at the time of aspiration. The remaining 43 (70.5%) healthy aspirated oocytes were classified according to the oocyte nuclear stage as germinal vesicle (GV), and germinal vesicle breakdown (MI). In all, 34 (79%) immature oocytes were considered as GV, and 9 (21%) were MI. Also, retrieval of immature oocyte that underwent IVM was performed in seven groups of patients. The maturation rates, the mean age of patients and the median number of aspirated oocytes in any types of diseases are presented in table 1. The median number of aspirated oocytes and maturation rate in patients with cervical neoplasia was higher than other groups. The findings also showed there was no correlation between patients age and the number of retrieved oocytes (R=0.09, n=26; p>0.05) (Figure 1). In addition, almost half of the patients were over age of 38 years.


Figure 1. Relationship between the age of the patients and the number of oocytes retrieved from ovarian tissue. Linear regression line. y=3.862_0.09x, R2=0.008 (p>0.05).


Morphologic observations
The data reveal that after IVM, the most frequent abnormalities in MII oocytes was wide PVS (36.3%), and dark cytoplasm (27.2%). Furthermore, the fPBs were observed in 38.4 percent of the matured oocytes. In addition, oocytes retrieved from one patient (30 years old) were found to have large sized irregular shape.
 
MS and ZP birefringence examination
With aid of Polscope, the MS could be visualized only in one of the IVM oocytes (Figure 2). However, the oocytes were divided into two groups based on the inner layer of ZP of MΙΙ oocyte: high/positively, and low/negative ZP birefringents. Finally, from these mature oocytes, 8 (61.5%) oocytes presented a high/positively scoring ZP and 5 (38.4%) with a low/negatively scoring ZP birefringents (Figure 3).


Figure 2. PolScope (OCTAX PolarAID; Octax, Herbon, Germany) image of an IVM human oocyte. A bright meiotic spindle (arrow) is clearly visible. ( ×40 magnification).



Figure 3. The inner layer of ZP of MΙΙ oocyte imaged with the Polscope. A) High ZP birefringent oocyte; B) Low ZP birefringent oocyte. ( ×40 magnification).


Table I. Oocyte yield and maturation rates in gynecologic patients who underwent IVM


Discussion
 
Under natural conditions, the ovaries of reproductive age patients contain a population of follicles in all growth stages. Oophorectomy can be performed for the purpose of fertility preservation in benign malignant diseases. Aspirating immature oocytes from ovaries is a milder treatment for infertility that caused by toxic chemotherapy. Furthermore, IVM technology does not require the use of large doses of gonadotropin for oocyte maturation. Also, it is feasible to reduce the risk of cancer recurrence rates. Moreover, the immature oocytes harvested from ovarian biopsies can be fertilized or vitrified after IVM. Therefore, IVM combined with the ovarian tissue freezing can be an additional strategy for fertility preservation (10). In this study, the immature oocytes collected from unstimulated ovaries showed a good developmental competence in gynecologic patients. Also, it has to be declared that almost half of our cases were over 38 years old. The IVM success rate that we achieved was 30.2%, which is higher than Wilken-Jensen et al. (2013) who reported only 3.1% maturation rate. In their study, 682 immature oocytes from surplus medulla tissue during cryopreservation of ovarian tissue were retrieved, but only 21 of them reached MII. They found that immature oocytes, obtained from ovary and subjected to a cooling period before recovery, had poor developmental competence (9). However, Imesch et al. (2013) showed a higher maturation rate of 61.9% (39/63) following IVM for up to 48 hr. Furthermore, the majority of these cases were non-cancerous patients (13). Fasano and associates (2011) and Escribá et al. (2012) also reported the maturation rates of 31% and 36.1%, respectively. They suggested that the major issue for decrease of IVM rate was delay in transport and oocyte collection from patients with oncological diseases (22-23). There are several factors for these different reports of IVM rates, such as source of oocytes (oncologic and nononcologic patients), IVM medium and technical procedures. Our data showed that the number of oocytes collected was negatively correlated with the patients’ age. This could be due to the experiment with less limitation for oophorectomy in aged patients compared to young women, similar to Fasano et al. (2011). They showed that for post-pubertal patients, there were no difference in the number of oocytes in patients who were less or over 30 year old (22). Conversely, Cha et al. (1998) reported that with advanced age, the number of immature oocytes that retrieved from an ovary were decreased (24). Also, Mohsenzadeh et al. (2012) showed that there was no significant relation between the rates of oocyte maturation and age of women. Their findings also demonstrated that IVM was useful for the majority of infertile cases (17).
Some studies have revealed that the quality of oocytes can be a determining factor in fertilization and embryonic developmental competence (19, 25). Oocyte is a complex cell with many organelles, such as MS and ZP that their dislocation or degeneration can decrease the oocyte viability (14). Omidi et al. (2013) and Nazari et al. (2011) demonstrated that following ovarian hyperstimulation of infertile women without any malignant disease, maturation rates were 65.9% and 59.4%, respectively. Also, most common anomaly in the IVM group was RF (15, 26). But in this study, wide PVS (36.3%) and dark cytoplasm (27.2%) were the most frequent abnormalities in IVM oocytes. In addition, fPB was noticed in some oocytes. Others observed that fPB was the most common anomaly in in vivo-matured oocytes (27, 28). Furthermore, Miao et al. (2004) concluded that fPB may be related to oocyte aging (29).
Analysis of oocyte morphological criteria, in combination with MS and the ZP visualization using the Polscope could be noninvasive and strong predictor of good quality oocytes. However,  Braga et al. ( 2008) and Omidi et al. (2013) observed the visible MS in most of the IVM oocytes (15, 30). Conversely, in this study, MS could be visualized only in one of the IVM oocytes. Raju et al. suggested that the temperature, maternal age and in-vitro manipulations of oocytes can influence the MS kinetics and morphology (31). Visualization using the Polscope reveals the ZP as a three-layer structure of glycoproteins that forms during oogenesis. Moreover, Lasienė et al. (2009) demonstrated the thickness of the ZP had no influence on the embryo development after ICSI (32). Braga et al. (2010) and Petersen et al. (2011) reported the ZP birefringence in human oocytes cannot be negatively influenced by IVM (33, 34). Omidi et al. (2013) showed a high/positive and low/negative scores of ZP based on the birefringence of the inner ZP layer (15). In the present study, 8 (61.5%) of the oocytes presented a HB ZP, while 5 (38.4%) oocytes showed LB ZP. Also, the LB ZP was detected in abnormal IVM oocytes, similar to those reported by Omidi et al. (2013) (15).
 
Conclusion
 
In conclusion, oocytes maturation post IVM from unstimulated ovaries seem to have good developmental potential in malignant and benign gynecologic patients. Therefore, further studies should be performed to advance the oocyte maturation program, such as co-culture system, for fertility preservation.
 
Acknowledgments
 
This study was supported by a grant from the Research and Clinical Center for Infertility, Shahid Sadughi University of Medical Sciences (Yazd, Iran).
 
Conflict of interest
 
There was no conflict of interest regarding our results.

 
Type of Study: Original Article |

References
1. Huang JY, Tulandi T, Holzer H, Tan SL, Chian R-C. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril 2008; 89: 567-572. [DOI:10.1016/j.fertnstert.2007.03.090]
2. Kim CH, Jeon GH. Fertility preservation in female cancer patients. ISRN obstet gynecol 2012; 2012: 807302.
3. Chung K, Donnez J, Ginsburg E, Meirow D. Emergency IVF versus ovarian tissue cryopreservation: decision making in fertility preservation for female cancer patients. Fertil steril 2013; 99: 1534-1542. [DOI:10.1016/j.fertnstert.2012.11.057]
4. Cromi A, Bogani G, Uccella S, Casarin J, Serati M, Ghezzi F. Laparoscopic fertility-sparing surgery for early stage ovarian cancer: a single-centre case series and systematic literature review. J Ovarian Res 2014; 7: 59. [DOI:10.1186/1757-2215-7-59]
5. Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil steril 2013; 99: 1476-1484. [DOI:10.1016/j.fertnstert.2013.03.029]
6. Fatemi HM, Kyrou D, Al-Azemi M, Stoop D, De Sutter P, Bourgain C, et al. Ex-vivo oocyte retrieval for fertility preservation. Fertil steril 2011; 95: 1787. [DOI:10.1016/j.fertnstert.2010.11.023]
7. Chian R-C, Uzelac PS, Nargund G. In vitro maturation of human immature oocytes for fertility preservation. Fertil steril 2013; 99: 1173-1181. [DOI:10.1016/j.fertnstert.2013.01.141]
8. Huang J, Tulandi T, Holzer H, Lau N, Macdonald S, Tan S, et al. Cryopreservation of ovarian tissue and in vitro matured oocytes in a female with mosaic Turner syndrome: case report. Hum Reprod 2008; 23: 336-339. [DOI:10.1093/humrep/dem307]
9. Wilken-Jensen HN, Kristensen SG, Jeppesen JV, Yding Andersen C. Developmental competence of oocytes isolated from surplus medulla tissue in connection with cryopreservation of ovarian tissue for fertility preservation. Acta Obstet Gynecol Scand 2014; 93: 32-37. [DOI:10.1111/aogs.12264]
10. Ata B, Chian R-C, Tan SL. Cryopreservation of oocytes and embryos for fertility preservation for female cancer patients. Best Pract Res Clin Obstet Gynaecol 2010; 24: 101-112. [DOI:10.1016/j.bpobgyn.2009.11.007]
11. Fadini R, Dal Canto M, Mignini Renzini M, Milani R, Fruscio R, Cantù MG, et al. Embryo transfer following in vitro maturation and cryopreservation of oocytes recovered from antral follicles during conservative surgery for ovarian cancer. J Assist Reprod Genet 2012: 29: 779-781. [DOI:10.1007/s10815-012-9768-0]
12. Revel A, Safran A, Benshushan A, Shushan A, Laufer N, Simon A. In vitro maturation and fertilization of oocytes from an intact ovary of a surgically treated patient with endometrial carcinoma: case report. Hum Reprod 2004; 19: 1608-1611. [DOI:10.1093/humrep/deh241]
13. Imesch P, Scheiner D, Xie M, Fink D, Macas E, Dubey R, et al. Developmental potential of human oocytes matured in vitro followed by vitrification and activation. J Ovarian Res 2013; 6: 30. [DOI:10.1186/1757-2215-6-30]
14. Khalili MA, Nottola SA, Shahedi A, Macchiarelli G. Contribution of human oocyte architecture to success of in vitro maturation technology. Iran J Reprod Med 2013; 11: 1-10.
15. Omidi M, Khalili MA, Ashourzadeh S, Rahimipour M. Zona pellucida birefringence and meiotic spindle visualisation of human oocytes are not influenced by IVM technology. Reprod Fertil Dev 2014; 26: 407-413. [DOI:10.1071/RD13001]
16. Molinari E, Evangelista F, Racca C, Cagnazzo C, Revelli A. Polarized light microscopy-detectable structures of human oocytes and embryos are related to the likelihood of conception in IVF. J Assisted Reprod Genet 2012; 29: 1117-1122. [DOI:10.1007/s10815-012-9840-9]
17. Mohsenzadeh M, Khalili MA, Nazari S, Jahromi VH, Agharahimi A, Halvaei I. Effect of vitrification on morphology and in-vitro maturation outcome of human immature oocytes. Ital J Anat Embryol 2012; 117: 190-198.
18. Yazdanpanah F, Khalili MA, Eftekhar M, Karimi H. The effect of vitrification on maturation and viability capacities of immature human oocytes. Arch Gynecol Obstet 2013; 288: 439-444. [DOI:10.1007/s00404-013-2777-0]
19. Khalili MA, Mojibian M, Sultan A-M. Role of oocyte morphology on fertilization and embryo formation in assisted reproductive techniques. Middle East Fertility Society Journal 2005; 10: 72-77.
20. Serhal P, Ranieri D, Kinis A, Marchant S, Davies M, Khadum I. Oocyte morphology predicts outcome of intracytoplasmic sperm injection. Hum Reprod 1997; 12: 1267-1270. [DOI:10.1093/humrep/12.6.1267]
21. Omidi M, Khalili MA, Nahangi H, Ashourzadeh S, Rahimipour M. Does women's age influence zona pellucida birefringence of metaphase ΙΙ oocytes in in-vitro maturation program? Iran J Reprod Med 2013; 11: 823-828.
22. Fasano G, Moffa F, Dechène J, Englert Y, Demeestere I. Vitrification of in vitro matured oocytes collected from antral follicles at the time of ovarian tissue cryopreservation. Reprod Biol Endocrinol 2011; 9: 150.
23. Escribá M-J, Grau N, Escrich L, Novella-Maestre E, Sánchez-Serrano M. Spontaneous in vitro maturation of oocytes prior to ovarian tissue cryopreservation in natural cycles of oncologic patients. J Assist Reprod Genet 2012; 29: 1261-1265.
24. Cha K-Y, Chian R-C. Maturation in vitro of immature human oocytes for clinical use. Hum Reprod Update 1998; 4: 103-120.
25. Xia P. Intracytoplasmic sperm injection: correlation of oocyte grade based on polar body, perivitelline space and cytoplasmic inclusions with fertilization rate and embryo quality. Hum Reprod 1997; 12: 1750-1755.
26. Nazari S, Khalili MA, Esmaielzadeh F, Mohsenzadeh M. Maturation capacity, morphology and morphometric assessment of human immature oocytes after vitrification and in-vitro maturation. Iran J Reprod Med 2011; 9: 209-216.
27. Rienzi L, Ubaldi FM, Iacobelli M, Minasi MG, Romano S, Ferrero S, et al. Significance of metaphase II human oocyte morphology on ICSI outcome. Fertil Steril 2008; 90: 1692-1700.
28. Halvaei I, Khalili MA, Razi MH, Nottola SA. The effect of immature oocytes quantity on the rates of oocytes maturity and morphology, fertilization, and embryo development in ICSI cycles. J Assist Reprod Genet 2012; 29: 803-810.
29. Miao Y, Ma S, Liu X, Miao D, Chang Z, Luo M, et al. Fate of the first polar bodies in mouse oocytes. Mol Reprod Dev 2004; 69: 66-76.
30. Braga DP, Figueira RdeS, Rodrigues D, Madaschi C, Pasqualotto FF, Iaconelli Jr A, et al. Prognostic value of meiotic spindle imaging on fertilization rate and embryo development in in vitro-matured human oocytes. Fertil Steril 2008; 90: 429-433.
31. Raju G, Prakash G, Krishna KM, Madan K. Meiotic spindle and zona pellucida characteristics as predictors of embryonic development: a preliminary study using PolScope imaging. Reprod Biomed Online 2007; 14: 166-174.
32. Lasienė K, Vitkus A, Valančiūtė A, Lasys V. Morphological criteria of oocyte quality. Medicina Kaunas 2009; 45: 509-515.
33. Braga DPdAF, Figueira RdCS, Queiroz P, Madaschi C, Iaconelli A, Borges E. Zona pellucida birefringence in in vivo and in vitro matured oocytes. Fertil Steril 2010; 94: 2050-2053.
34. Petersen CG, Vagnini LD, Mauri AL, Massaro FC, Silva LF, Cavagna M, et al. Evaluation of zona pellucida birefringence intensity during in vitro maturation of oocytes from stimulated cycles. Reprod Biol Endocrinol 2011; 9: 53.  

Send email to the article author


© 2021 All Rights Reserved | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb